Accumulation of 10 years of clinical (plastic, beauty industry) experience in the medical device and aesthetic beauty industry

Through the development of the medical device business, we are focusing on human health promotion projects in the 21st century.

According to iData, a medical market researcher, Europe and the United States account for the largest share of the global dental implant market. Europe accounts for 34.3% of the total implant value and the United States 29.5% each year, with these two regions accounting for about 64% of the total market.

Asia-Pacific, the world’s top market in the future, is the third largest, accounting for 28.1% and South America 8.1%.

The world’s population is growing by 82 million people a year.

In addition, the Asian beauty aesthetic and medical device market is rapidly growing in China and India. Based on its experience in the medical industry in India, the Middle East, and Africa, Roche BNH is focusing on expanding and exporting the market with the spearhead of K Medical, manufacturing, R&D, and education services, which are the core of the K bio business in Korea, through active marketing and technology development in the global network niche.

Based on India’s own clean room manufacturing facilities, executives and employees will complete a new business model for Korea and India at 1.4 billion won in India to lead to continuous and rapid K Medical spearhead.

In addition, it will be a frontier for the job creation and high value-added medical industry in the 21st century medical industry in Korea and India.